IQVIA's AI Gamble: Will Clinical Trials Pay Off?

IQVIA stock jumps on new AI clinical trial tool! Find out how the tech giant's AI push and strategic partnerships are impacting its share price and why Wall Street is cautiously optimistic about IQVIA's future in the evolving landscape of clinical research. Hosted on Acast. See acast.com/privacy for more information.